Nuveen Asset Management, LLC Novo Nordisk A S Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 3,605,238 shares of NVO stock, worth $315 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,605,238

Previous 3,518,996 2.45%

Holding current value

$315 Million

Previous $502 Million 14.54%

% of portfolio

0.12%

Previous 0.15%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $10.3 Million - $12.5 Million	86,242 Added 2.45%	3,605,238 $429 Million
Q2 2024 Aug 09, 2024	SELL	$122.71 - $146.91 $18.8 Million - $22.5 Million	-153,290 Reduced 4.17%	3,518,996 $502 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $53.6 Million - $71.4 Million	525,211 Added 16.69%	3,672,286 $472 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $3.63 Million - $4.36 Million	-41,389 Reduced 1.3%	3,147,075 $326 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $146 Million - $320 Million	1,605,723 Added 101.45%	3,188,464 $290 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $66.3 Million - $73.4 Million	425,039 Added 36.71%	1,582,741 $256 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $61.8 Million - $74.3 Million	466,807 Added 67.57%	1,157,702 $184 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $70.9 Million - $93.5 Million	690,895 New	690,895 $93.5 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $5.29 Million - $6.4 Million	-56,827 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $1.31 Million - $1.6 Million	-13,627 Reduced 19.34%	56,827 $6.37 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $253 - $319	-3 Reduced -0.0%	70,454 $6.76 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $21,660 - $24,489	323 Added 0.46%	70,457 $4.75 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $11,564 - $13,357	-181 Reduced 0.26%	70,134 $4.9 Million
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $13,820 - $15,237	-217 Reduced 0.31%	70,315 $4.88 Million
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $15,747 - $18,275	-269 Reduced 0.38%	70,532 $4.62 Million
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $6,726 - $8,810	-136 Reduced 0.19%	70,801 $4.26 Million
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $3.54 Million - $4.13 Million	70,937 New	70,937 $4.11 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Novo Nordisk A S Transaction History